Dr. Adrian M Senderowicz MD
Oncologist | Medical Oncology
9406 Linden Ave Bethesda MD, 20814About
Dr. Adrian Senderowicz is an oncologist practicing in Bethesda, MD. Dr. Senderowicz specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Senderowicz manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Education and Training
Univ De Buenos Aires- Fac De Med- Buenos Aires- Argentina 1987
Universidad de Buenos Aires Facultad de Medicina 1988
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Induction of differentiation accompanies inhibition of Cdk2 in a non-small cell lung cancer cell line.
- Identification of cytosolic aldehyde dehydrogenase 1 from non-small cell lung carcinomas as a flavopiridol-binding protein.
- Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol.
- Flavopiridol, a protein kinase inhibitor, down-regulates hypoxic induction of vascular endothelial growth factor expression in human monocytes.
- Induction of apoptosis and inhibition of c-erbB-2 in breast cancer cells by flavopiridol.
- Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials.
- Modulation of clinical drug resistance in a B cell lymphoma patient by the protein kinase inhibitor 7-hydroxystaurosporine: presentation of a novel therapeutic paradigm.
- Inhibition of CDKs as a therapeutic modality.
- Induction of growth inhibition and apoptosis in prostate cancer cells by flavopiridol.
- Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.
- Development of cyclin-dependent kinase modulators as novel therapeutic approaches for hematological malignancies.
- Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms.
- First symposium of novel molecular targets for cancer therapy.
- Characterization of autoantibodies against uridine-diphosphate
- Small molecule modulators of cyclin-dependent kinases for cancer therapy.
Dr. Adrian M Senderowicz MD's Practice location
Dr. Adrian M Senderowicz MD's reviews
Write ReviewPatient Experience with Dr. Senderowicz
Recommended Articles
- Can High Blood Pressure Benefit Those with Ovarian Cancer?
Ovarian cancer is the most fatal of all reproductive cancers that women face. Fewer than half of the women diagnosed with ovarian cancer will survive more than five years after their diagnosis, leading to over 152,000 deaths each and every year. Cancer research programs are constantly trying to find...
- Reasons Why You Need a Biopsy
OverviewA biopsy is a procedure that involves the removal of a sample tissue in the body to examine it closely under a microscope. The tissue is mainly examined to diagnose a certain disease. Some may use a needle or surgical methods to remove any lumps or suspicious nodules in the body. Some...
- Which Specialist Performs a Hysterectomy?
In the U.S., hysterectomies are second only to cesarean deliveries among the most widely-adopted surgical practices, and the number of women opting to go under the knife exceeds half a million annually. Your choice of specialist for the surgery depends entirely on the nature and seriousness of the...
- Can Multiple Myeloma be Asymptomatic?
Early treatment for persons suffering from multiple myeloma that is asymptomatic may not be beneficial. The initial stages for multiple myeloma do not show symptoms, and this is known as being asymptomatic.The treatment for persons with asymptomatic multiple myeloma should be deferred up to when the...
- How is Lung Cancer Diagnosed?
Lung Cancer is one of the most common and serious forms of cancers in the world. In fact, it is also one of the leading causes of cancer deaths for both men and women. This form of cancer is known to mainly affect older people, primarily those in their seventies. Smoking has been identified as one...
- Why Is Hereditary Ovarian Cancer Risk on the Rise in India?
Ovarian cancer is one of the more serious cancers which can affect women. It is the seventh most common cause of cancer in women, affecting one in twenty-eight women. The symptoms can be difficult to detect, as they mimic the effects of other, less dangerous diseases. When caught early, most women...
Nearby Providers
- Martin M. Malawer7830 Old Georgetown Road Bethesda Maryland 20814
- Dr. Joseph A Fiorillo MD8600 Old Georgetown Rd Bethesda MD 20814
- Dr. Giselle Mery M.D.4416 E West Hwy Bethesda MD 20814
- Dr. Robert S.k. Young M.D.9415 Spruce Tree Cir Bethesda MD 20814
- Dr. Robert Lechleider M.D.116 N BROOK LN BETHESDA MD 20814